Dasatinib synergises with irinotecan to suppress hepatocellular carcinoma via inhibiting the protein synthesis of PLK1.
about
Dasatinib synergises with irinotecan to suppress hepatocellular carcinoma via inhibiting the protein synthesis of PLK1.
description
2017 nî lūn-bûn
@nan
2017 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2017 թվականի մարտին հրատարակված գիտական հոդված
@hy
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
name
Dasatinib synergises with irin ...... the protein synthesis of PLK1.
@ast
Dasatinib synergises with irin ...... the protein synthesis of PLK1.
@en
Dasatinib synergises with irin ...... the protein synthesis of PLK1.
@nl
type
label
Dasatinib synergises with irin ...... the protein synthesis of PLK1.
@ast
Dasatinib synergises with irin ...... the protein synthesis of PLK1.
@en
Dasatinib synergises with irin ...... the protein synthesis of PLK1.
@nl
prefLabel
Dasatinib synergises with irin ...... the protein synthesis of PLK1.
@ast
Dasatinib synergises with irin ...... the protein synthesis of PLK1.
@en
Dasatinib synergises with irin ...... the protein synthesis of PLK1.
@nl
P2093
P2860
P356
P1476
Dasatinib synergises with irin ...... the protein synthesis of PLK1.
@en
P2093
Guanqun Li
Jinjin Shao
Peihua Luo
Qiaojun He
Yuanrun Zhu
P2860
P2888
P304
P356
10.1038/BJC.2017.55
P407
P577
2017-03-07T00:00:00Z
P6179
1084127740